Cantor Fitzgerald Starts Qualcomm (QCOM) at Buy; The Dominator
Tweet Send to a FriendGet Alerts QCOM Hot Sheet
Price: $61.91 -0.75%
Rating Summary:
24 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
24 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade QCOM Now!
Cantor Fitzgerald initiates coverage on Qualcomm (NASDAQ: QCOM) with a Buy. PT $66.00.
Analyst, Dale R. Pfau, said, "We are bullish on the long-term trends in wireless devices, however, in the near term, we are slightly concerned about dislocations due to the 28 nm capacity issue and potential impacts due to macro-economic events. Therefore, our estimates are below consensus (but within guidance) for 3Q:12 and FY:12. Our estimates for Fiscal 2013 and 2014 are above consensus ($4.33 & $4.99)."
For an analyst ratings summary and ratings history on Qualcomm click here. For more ratings news on Qualcomm click here.
Shares of Qualcomm closed at $54.91 yesterday, with a 52 week range of $45.98-$68.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Dale R. Pfau, said, "We are bullish on the long-term trends in wireless devices, however, in the near term, we are slightly concerned about dislocations due to the 28 nm capacity issue and potential impacts due to macro-economic events. Therefore, our estimates are below consensus (but within guidance) for 3Q:12 and FY:12. Our estimates for Fiscal 2013 and 2014 are above consensus ($4.33 & $4.99)."
For an analyst ratings summary and ratings history on Qualcomm click here. For more ratings news on Qualcomm click here.
Shares of Qualcomm closed at $54.91 yesterday, with a 52 week range of $45.98-$68.87.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Keryx Biopharma (KERX) Patents Strong; JPMorgan Starts at Overweight
- Wedbush Starts USG Corp. (USG) at Neutral
- Deutsche Bank Starts Quintiles (Q) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor Fitzgerald
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
